查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363069

呼吸系統疾病檢測市場規模、佔有率和趨勢分析報告：按產品、最終用途、用途、地區和細分市場預測，2023-2030 年

Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

呼吸系統疾病檢測市場的成長與趨勢：

根據 Grand View Research, Inc. Masu 的最新報告，預計到 2030 年，全球呼吸系統疾病檢測市場規模將達到 77.5 億美元，2023 年至 2030 年年複合成長率為 2.8%。

該市場是由呼吸系統疾病患病患病上升所推動的。根據國際呼吸學會論壇統計，2014年全球有超過2億人罹患慢性阻塞性肺病（COPD），2.35億人患有氣喘。此外，年度有超過5000萬人患有職業性肺病。因此，不斷增加的目標患者群體預計將推動成長。

採用電腦斷層掃描 (CT) 等創新技術進行慢性阻塞性肺病診斷預計將推動成長。慢性阻塞性肺病急性醫療管理的另一項新技術是脈搏血氧測定法，用於門診病人監測。呼吸道管理在 COPD 的檢測和管理中發揮著重要作用。最近的創新也導致用於 COPD 治療的非侵入性機械通氣 (NIV) 的使用增加了 12.1%。隨著技術的進步，數位放射線成像（X 光）和先進的攜帶式肺活量計的使用在呼吸系統疾病測試/診斷市場中越來越受歡迎。

呼吸系統疾病檢測市場報告亮點

  • 呼吸系統疾病患病的增加和技術的快速進步是預計推動市場成長的兩個關鍵因素。
  • 從按產品來看，由於創新技術的快速發展和採用，影像檢查在2022年佔據最大佔有率。
  • 從用途來看，由於全球患病不斷上升，結核病將在 2022 年成為最大的市場。
  • 按最終用途，醫院領域在 2022 年佔據最大佔有率，由於住院人數增加和對住院治療的偏好增加，預計在預測期內將出現成長。
  • 2022年，北美在呼吸道疾病檢測市場佔據主導地位。慢性阻塞性肺病、氣喘呼吸道疾病的患病不斷增加，對早期診斷的需求增加，以及患者對早期診斷益處的認知不斷提高，這些都是促成這一優勢的要素。
  • 預計亞太地區在預測期內將以最快的速度成長。這一成長歸因於多種要素，包括醫療保健基礎設施的改善以及患者對慢性阻塞性肺病和氣喘等呼吸系統疾病新診斷技術可用性的認知提高。
  • 該市場的主要競爭主要企業包括但不限於 Becton Dickinson (Carefusion Corporation)、Koninklijke Philips NV (Respironics)、ResMed Company、Fischer & Paykel 和 Medtronic。這些公司在呼吸系統疾病診斷市場擁有成熟的產品系列，並且是市場上的強勢品牌。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 呼吸系統疾病檢測市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 呼吸系統疾病檢測市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 呼吸道疾病檢測：產品估算與趨勢分析

  • 呼吸系統疾病檢測市場：重點
  • 呼吸道疾病檢測市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 影像檢查
    • 2018年至2030年影像檢查市場估計與預測
  • 呼吸檢測設備
    • 2018年至2030年呼吸檢測設備市場估計與預測
  • 血氣測試
    • 2018年至2030年血液氣體檢測市場估計與預測
  • 其他
    • 2018 年至 2030 年其他市場估計與預測

第5章 呼吸系統疾病檢測：應用評估與趨勢分析

  • 呼吸系統疾病檢測市場：重點
  • 呼吸道疾病檢測市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 慢性阻塞性肺病
  • 肺癌
  • 氣喘
  • 結核
  • 其他

第6章 呼吸道疾病檢測：最終用途估算與趨勢分析

  • 呼吸系統疾病檢測市場：重點
  • 呼吸道疾病檢測市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院
    • 2018年至2030年醫院市場估計與預測
  • 醫生辦公室
    • 2018年至2030年醫師診所市場估計與預測
  • 臨床實驗室
    • 2018年至2030年臨床檢測市場估計與預測
  • 其他
    • 2018 年至 2030 年其他市場估計與預測

第7章 呼吸系統疾病檢測市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的呼吸系統疾病檢測市場：市場要點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Abbott
    • BD
    • Koninklijke Philips NV
    • ResMed
    • Fisher & Paykel Appliances Ltd
    • Medtronic
    • BIOMERIEUX
    • Carestream Health
    • SDI Diagnostics
    • Siemens Healthcare GmbH
Product Code: GVR-1-68038-807-7

Respiratory Disease Testing Market Growth & Trends:

The global respiratory disease testing market size is expected to reach USD 7.75 billion by 2030, registering a CAGR of 2.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than 200 million people across the globe suffered from Chronic Obstructive Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In addition, the source stated that more than 50 million people struggle with occupational lung diseases annually. Thus, constantly growing target patient population is anticipated to drive the growth.

The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring. Airway management plays a main role in testing and management of COPD. Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the respiratory disease testing/diagnostics market.

Respiratory Disease Testing Market Report Highlights:

  • Growing prevalence of respiratory diseases and rapid technological advancements are two of the major factors expected to propel the market growth
  • Based on products, imaging tests held the largest share in 2022 due to rapid development and adoption of innovative technologies
  • Based on application, tuberculosis was the largest market in 2022 owing to rising prevalence of the disease globally
  • Based on end-use, hospitals segment held the largest share in 2022 and is anticipated to grow over the forecast period due to an increase in hospitalization and a growing preference for hospital treatment
  • North America dominated the respiratory disease testing market in 2022. Growing prevalence of respiratory diseases such as COPD, & asthma, increasing demand for early diagnosis, and rising awareness amongst patients about the benefits of early diagnosis are responsible for the dominance
  • Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors, such as improving healthcare infrastructure and increasing patient awareness regarding the availability of new diagnostic techniques for respiratory diseases, such as COPD & asthma
  • Some of the major players competing in this market include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company; Fischer & Paykel; and Medtronic. These players are strong brands in the market as they have elaborate product portfolios in respiratory disease diagnostics market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Respiratory Disease Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Respiratory Disease Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Respiratory Disease Testing: Product Estimates & Trend Analysis

  • 4.1. Respiratory Disease Testing Market: Key Takeaways
  • 4.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Imaging Tests
    • 4.3.1. Imaging tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Respiratory Measurement devices
    • 4.4.1. Respiratory measurement devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Blood Gas Test
    • 4.5.1. Blood gas test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Respiratory Disease Testing: Application Estimates & Trend Analysis

  • 5.1. Respiratory Disease Testing Market: Key Takeaways
  • 5.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Chronic Obstructive Pulmonary Disease
    • 5.3.1. Chronic obstructive pulmonary disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Lung Cancer
    • 5.4.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Asthma
    • 5.5.1. Asthma market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Tuberculosis
    • 5.6.1. Tuberculosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Respiratory Disease Testing: End-use Estimates & Trend Analysis

  • 6.1. Respiratory Disease Testing Market: Key Takeaways
  • 6.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospital
    • 6.3.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Physicians Clinic
    • 6.4.1. Physician clinic market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Clinical Laboratories
    • 6.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Respiratory Disease Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Respiratory Disease Testing Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. BD
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Koninklijke Philips N.V.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. ResMed
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Fisher & Paykel Appliances Ltd
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. BIOMERIEUX
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Carestream Health
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. SDI Diagnostics
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Siemens Healthcare GmbH
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 23 France respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 France respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 48 China respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 49 China respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 51 India respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 India respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Thailand respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Thailand respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Australia respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Respiratory disease testing: Market outlook
  • Fig. 9 Respiratory disease testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Respiratory disease testing market driver impact
  • Fig. 15 Respiratory disease testing market restraint impact
  • Fig. 16 Respiratory disease testing market strategic initiatives analysis
  • Fig. 17 Respiratory disease testing market: Product movement analysis
  • Fig. 18 Respiratory disease testing market: Product outlook and key takeaways
  • Fig. 19 Imaging tests market estimates and forecasts, 2018 - 2030
  • Fig. 20 Respiratory measurement devices market estimates and forecasts, 2018 - 2030
  • Fig. 21 Blood gas test market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030
  • Fig. 23 Respiratory disease testing market: Application movement analysis
  • Fig. 24 Respiratory disease testing market: Application outlook and key takeaways
  • Fig. 25 Chronic obstructive pulmonary disease market estimates and forecasts, 2018 - 2030
  • Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030
  • Fig. 27 Asthma market estimates and forecasts, 2018 - 2030
  • Fig. 28 Tuberculosis market estimates and forecasts, 2018 - 2030
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030
  • Fig. 30 Respiratory disease testing market: End-use movement analysis
  • Fig. 31 Respiratory disease testing market: End-use outlook and key takeaways
  • Fig. 32 Hospital market estimates and forecasts, 2018 - 2030
  • Fig. 33 Physicians clinic market estimates and forecasts, 2018 - 2030
  • Fig. 34 Clinical laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030
  • Fig. 36 Global Respiratory Disease Testing Market: Regional Movement Analysis
  • Fig. 37 Global Respiratory disease testing market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 44 France market estimates and forecasts, 2018 - 2030
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 52 China market estimates and forecasts, 2018 - 2030
  • Fig. 53 India market estimates and forecasts, 2018 - 2030
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 61 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 63 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030